Contec Research Development from 2010 to 2024
| 300869 Stock | 15.12 0.77 4.85% |
Research Development | First Reported 2019-09-30 | Previous Quarter 27.1 M | Current Value 28.9 M | Quarterly Volatility 7 M |
Check Contec Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Contec Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.9 M, Interest Expense of 47.4 M or Selling General Administrative of 10 M, as well as many indicators such as . Contec financial statements analysis is a perfect complement when working with Contec Medical Valuation or Volatility modules.
Contec | Research Development |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Contec Stock
Contec Medical financial ratios help investors to determine whether Contec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Contec with respect to the benefits of owning Contec Medical security.